The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
COMy 2019 | Update on WM biology and therapy
Steven Treon
• 16 May 2019
Steven Treon, MD, PhD, from the Dana-Farber Cancer Institute, Boston, MA, reviews the most promising updates in Waldenström’s Macroglobulinemia. Treatment options are expanding in the field with the identification of key targets MYD, CXCR4 and Bcl-2. This interview took place at the Controversies in Multiple Myeloma (COMy) 2019 World Congress in Paris, France.
